D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$402M |
| 2 |
AGN
Allergan plc
AGN
|
+$371M |
| 3 |
Bank of America
BAC
|
+$323M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$236M |
Top Sells
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$364M |
| 4 |
Phillips 66
PSX
|
+$352M |
| 5 |
Apple
AAPL
|
+$350M |
Sector Composition
| 1 | Healthcare | 15.91% |
| 2 | Technology | 12.6% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Communication Services | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Aon
AON
$78.6B
| $20.5M | 0.04% |
196,694
+62,776
| +47% | +$6.56M |
|
|
MNDT
402
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $20.5M | 0.04% |
1,141,807
+921,291
| +418% | +$16.6M |
|
403
Nice
NICE
$8.9B
| $20.5M | 0.04% |
316,702
+10,224
| +3% | +$662K |
|
|
RAI
404
DELISTED
Reynolds American Inc
RAI
| $20.5M | 0.04% |
+407,175
| New | +$20.5M |
|
|
MIK
405
DELISTED
Michaels Stores, Inc
MIK
| $20.4M | 0.04% |
730,228
+11,760
| +2% | +$329K |
|
406
Light & Wonder
LNW
$7.4B
| $20.3M | 0.04% |
2,155,316
+84,556
| +4% | +$797K |
|
|
WY.PRA
407
DELISTED
WEYERHAEUSER COMP PREF CONV SER A (WA)
WY.PRA
| $20.3M | 0.04% |
398,535
+200,000
| +101% | +$10.2M |
|
408
Quest Diagnostics
DGX
$20.3B
| $20.2M | 0.04% |
282,885
+149,134
| +112% | +$10.7M |
|
|
TIME
409
DELISTED
Time Inc.
TIME
| $20.2M | 0.04% |
1,305,608
-335,048
| -20% | -$5.17M |
|
410
Kroger
KR
$44.5B
| $20.1M | 0.04% |
526,725
+82,613
| +19% | +$3.16M |
|
|
FCE.A
411
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $20.1M | 0.04% |
952,571
-667,737
| -41% | -$14.1M |
|
|
GNC
412
DELISTED
GNC Holdings, Inc.
GNC
| $19.9M | 0.04% |
627,958
+470,227
| +298% | +$14.9M |
|
|
LXK
413
DELISTED
Lexmark Intl Inc
LXK
| $19.9M | 0.04% |
595,217
+310,107
| +109% | +$10.4M |
|
414
Wolverine World Wide
WWW
$2.55B
| $19.9M | 0.04% |
1,079,139
+323,704
| +43% | +$5.96M |
|
|
IMS
415
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $19.5M | 0.04% |
734,331
+270,223
| +58% | +$7.17M |
|
416
Corpay
CPAY
$21.9B
| $19.3M | 0.03% |
129,883
+7,136
| +6% | +$1.06M |
|
417
LiveRamp
RAMP
$1.77B
| $19.3M | 0.03% |
898,603
+175,800
| +24% | +$3.77M |
|
418
Materials Select Sector SPDR Fund
XLB
$5.46B
| $19.1M | 0.03% |
+427,035
| New | +$19.1M |
|
|
DCUA
419
DELISTED
DOMINION RESOURCES INC. CORP UNIT 2013 SER A (VA)
DCUA
| $19.1M | 0.03% |
325,000
| – | – |
|
|
QGENF
420
DELISTED
QIAGEN NV
QGENF
| $19M | 0.03% |
852,219
+792,753
| +1,333% | +$17.7M |
|
421
Texas Roadhouse
TXRH
$11B
| $19M | 0.03% |
436,569
+371,006
| +566% | +$16.2M |
|
422
Check Point Software Technologies
CHKP
$21.1B
| $18.9M | 0.03% |
216,565
-285,823
| -57% | -$25M |
|
|
TCO
423
DELISTED
Taubman Centers Inc.
TCO
| $18.9M | 0.03% |
265,684
+224,730
| +549% | +$16M |
|
424
BioMarin Pharmaceuticals
BMRN
$10.5B
| $18.8M | 0.03% |
228,272
-169,822
| -43% | -$14M |
|
425
GSK
GSK
$81.4B
| $18.8M | 0.03% |
+370,460
| New | +$18.8M |
|